Zusduri™ (mitomycin)
for Urothelial Cancer
Zusduri (mitomycin) is used to treat recurrent low-grade, intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC) in adults after unsuccessful bladder surgery. It works by blocking cancer cells from making DNA, which is needed for growth and division. Zusduri, an alkylating agent, forms links within DNA molecules and, at high doses, also blocks RNA and protein production.
